Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients with established liver cirrhosis (biopsy or biochemically)~* hepatorenal syndrome type 1 or 2 (with a serum creatinin \>175 umol/l)~* age between 18 and 75~* no bacterial infection~* no cardiovascular or extrahepatic disease (end of life)~* no structural kidney disease~* no hepatocellular carcinoma~Exclusion Criteria:~* age under 15 or over 75~* treatment with corticosteroids (dexamethasone included)~* bacterial infection~* cardiovascular or extrahepatic disease (end of life)~* structural kidney disease (indicated by hematuria, proteinuria)~* hepatocellular carcinoma~* mental disability

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Dexamethasone (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).